反应性氧物种相关的状纳米架构用于生物科学
Guangbo Yu1, Aihua Qu1, Zhimeng Wu2
1International Joint Research Laboratory for Biointerface and Biodetection State Key Lab of Food Science and Technology School of Food Science and Technology Wuxi Jiangsu 214122 PRC.
状纳米材料利用独特的光学活性来调节活性氧物种 (ROS),在纳米生物学中提供显著的生物效应. 本综述探讨了它们的构建,应用以及在ROS监管中的未来潜力.
科学领域:
- 纳米生物学的纳米生物学
- 生物医学科学 生物医学科学
- 材料科学 材料科学 材料科学
背景情况:
- 奇拉性是生命和生物过程的基础.
- 状纳米材料表现出独特的光学活性,对生物相互作用至关重要.
- 反应性氧物种 (ROS) 的调节对于细胞和体内生物的功能至关重要.
研究的目的:
- 审查生物科学中性纳米材料的进展.
- 引入用于构建与ROS相关的性纳米材料的策略.
- 讨论在ROS监管中性纳米材料的生物效应和未来前景.
主要方法:
- 在生物科学中应用奇拉纳米材料的文献综述.
- 对ROS调节性性纳米材料的构造策略的分类.
- 通过性纳米材料通过ROS调节实现的生物效应的分析.
主要成果:
- 可以合成各种性纳米材料与ROS相互作用.
- 由性纳米材料对ROS的调制导致了多样化的生物结果.
- 该领域显示出治疗和诊断应用的巨大潜力.
结论:
- 状纳米材料为控制生物系统中的ROS提供了一个有希望的平台.
- 需要进一步的研究来应对关键的挑战,并释放充分的治疗潜力.
- 未来的前景包括先进的设计和有针对性的交付,以加强ROS监管.
更多相关视频
13:37Template Directed Synthesis of Plasmonic Gold Nanotubes with Tunable IR Absorbance
Published on: April 1, 2013
14:43Microfluidic On-chip Capture-cycloaddition Reaction to Reversibly Immobilize Small Molecules or Multi-component Structures for Biosensor Applications
Published on: September 23, 2013
相关概念视频
Chirality in Nature
Prochirality
Chirality
Chiral objects exhibit a sense of handedness when they interact with another chiral object. For example, our left foot can only fit in the left shoe and not in the right shoe. Achiral objects — objects that have...
Chirality at Nitrogen, Phosphorus, and Sulfur
A consequence of chirality is the need for enantiomeric resolution. While this is theoretically possible for all...
Molecules with Multiple Chiral Centers
Stereoisomerism
Isomers are different chemical species that have the same chemical formula.
Transition metal complexes often exist as geometric isomers, in which the same atoms are connected through the same types of bonds but with differences in their orientation in space. Coordination complexes with two different ligands in the cis and trans positions from a ligand of interest form isomers. For example, the octahedral [Co(NH3)4Cl2]+ ion has two isomers (Figure 1) In the cis...
